dinitrofluorobenzene has been researched along with Neoplasm Metastasis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Berd, D; Mastrangelo, MJ; Sato, T | 1 |
| Berd, D; Cohn, H; Maguire, HC; Mastrangelo, MJ; Sato, T | 1 |
1 trial(s) available for dinitrofluorobenzene and Neoplasm Metastasis
| Article | Year |
|---|---|
Effect of the dose and composition of an autologous hapten-modified melanoma vaccine on the development of delayed-type hypersensitivity responses.
Topics: Adjuvants, Immunologic; Adolescent; Adult; Aged; Aged, 80 and over; BCG Vaccine; Cancer Vaccines; Cell Count; Cell Survival; Combined Modality Therapy; Cyclophosphamide; Dinitrofluorobenzene; Dose-Response Relationship, Immunologic; Female; Haptens; Humans; Hypersensitivity, Delayed; Immunization Schedule; Injections, Intradermal; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Neoplastic Stem Cells | 2002 |
1 other study(ies) available for dinitrofluorobenzene and Neoplasm Metastasis
| Article | Year |
|---|---|
Treatment of metastatic melanoma with autologous, hapten-modified melanoma vaccine: regression of pulmonary metastases.
Topics: Adult; Aged; Aged, 80 and over; Cancer Vaccines; Dinitrofluorobenzene; Disease-Free Survival; Female; Haptens; Humans; Hypersensitivity, Delayed; Immunotherapy; Inflammation; Lung Neoplasms; Male; Melanoma; Middle Aged; Multivariate Analysis; Neoplasm Metastasis; Skin Neoplasms; Time Factors; Treatment Outcome; Vaccines | 2001 |